Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,260 | -14,084 | -47,939 | -33,349 | -22,159 |
| Depreciation Amortization | 392 | 185 | 848 | 419 | 261 |
| Accounts payable and accrued liabilities | 400 | 525 | -97 | -119 | -272 |
| Other Working Capital | 2,672 | 932 | 1,388 | 1,565 | 308 |
| Other Operating Activity | 4,581 | 1,795 | 11,036 | 9,045 | 7,591 |
| Operating Cash Flow | $-22,215 | $-10,647 | $-34,764 | $-22,439 | $-14,271 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -639 | -434 | -2,013 | -1,010 | -808 |
| Purchase Of Investment | -36,130 | N/A | -82,627 | -82,611 | -42,552 |
| Sale Of Investment | 12,500 | 7,500 | 9,995 | 2,495 | 0 |
| Other Investing Activity | 264 | 0 | -1,116 | -1,116 | -1,116 |
| Investing Cash Flow | $-24,005 | $7,066 | $-75,761 | $-82,242 | $-44,476 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -5,026 | -5,026 | -5,026 |
| Common Stock Issued | 46,136 | 224 | 95,023 | 94,927 | 94,910 |
| Other Financing Activity | -75 | -75 | 0 | 0 | 0 |
| Financing Cash Flow | $46,061 | $149 | $89,997 | $89,901 | $89,884 |
| Beginning Cash Position | 26,067 | 26,067 | 46,595 | 46,595 | 46,595 |
| End Cash Position | 25,908 | 22,635 | 26,067 | 31,815 | 77,732 |
| Net Cash Flow | $-159 | $-3,432 | $-20,528 | $-14,780 | $31,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,215 | -10,647 | -34,764 | -22,439 | -14,271 |
| Capital Expenditure | -639 | -434 | -2,013 | -1,010 | -808 |
| Free Cash Flow | -22,854 | -11,081 | -36,777 | -23,449 | -15,079 |